About Dominant hypophosphatemia with nephrolithiasis or osteoporosis
Dominant hypophosphatemia with nephrolithiasis or osteoporosis is a rare disease catalogued by Orphanet (ORPHA:244305). It is associated with the SLC34A1, NHERF1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Dominant hypophosphatemia with nephrolithiasis or osteoporosis trials.
Search ClinicalTrials.gov for "Dominant hypophosphatemia with nephrolithiasis or osteoporosis" or filter by Orphanet code ORPHA:244305 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Dominant hypophosphatemia with nephrolithiasis or osteoporosis trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Dominant hypophosphatemia with nephrolithiasis or osteoporosis. Updated daily.